Hansa Medical will present the drug candidate IdeS’s potential as a novel treatment for desensitization prior to kidney transplantation, at the poster session on July 27 at the 2014 World Transplant Congress in San Francisco, USA. The World Transplant Congress gathers international experts on transplantation, attracts prominent keynote speakers as well as pharmaceutical and biotechnology companies committed to the improvement of treatment of transplantation patients.
Help employers find you! Check out all the jobs and post your resume.
